Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical ...

As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...

Richie Murphy expressed his delight after Ulster left the Dexcom Stadium in Galway with a bonus point victory over Connacht.

CONNACHT host Ulster at the Dexcom Stadium in the first of today’s URC inter-provincial derbies. Before Munster and Leinster ...

Significant changes at Johnson & Johnson were among the most-read medtech news on MassDevice over the past year.

Ulster centre Stuart McCloskey believes the side have "still got loads to work on" despite a largely strong start to their ...

The average rate on a 30-year U.S. mortgage ticked down modestly this week, remaining in the same narrow range of the past two months. The average long-term mortgage rate fell to ...

Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit.

SIGN UP FOR THE AT: https://www.ktmc.com/new-cases/dexcom-inc-1?utm_source=NewMediaWire&mktm=PR ...

Please CLICK HERE to view our video or copy and paste this link into your browser: https://youtube.com/shorts/ToTm4-K0ODs?feature=share ...

Real-time continuous glucose monitoring (rt-CGM) reduced large-for-gestational-age (LGA) births in women with gestational diabetes.

In a report released on December 16, William Plovanic from Canaccord Genuity maintained a Buy rating on Dexcom, with a price target of $99.00. The company’s shares closed yesterday at $66.37.